TAVR slightly ups long-term stroke risk
10 May 2021
The long-term risk of stroke seems to be higher in patients after transcatheter aortic valve replacement (TAVR), though some uncertainty remains whether such an effect is caused by predisposing risk factors or not, a recent study has found.
Contents : Per 100 u/mL + 50 mcg/mL soln for inj (10-40 pen) Insulin glargine 3.64 mg (equiv to 100 u), lixisenatide 50 mcg. Per 100 u/mL + 33 mcg/mL soln for inj (30-60 pen) Insulin glargine 3.64 mg (equiv to 100 u), lixisenatide 33 mcg
Indications/Uses : In combination w/ metformin for adults w/ type 2 DM to improve glycaemic control when metformin alone, or metformin combined w/ another oral glucose lowering drugs, or w/ basal insulin does not provide adequate glycaemic control.